Quality of Life Study | 2026 Mid-Year Update | Eugene Kwon, MD + Mark Moyad, MD Q&A #PCRI @ThePCRI
Quality of Life Study | 2026 Mid-Year Update | Eugene Kwon, MD + Mark Moyad, MD Q&A #PCRI  @ThePCRI
Uploaded July 2026 | Updated September 2026, 2 weeks ago
Find Dr. Kwon's full presentation here:
youtube.com/watch?v=8iqO1Rvvxs4

00:00 Introduction to the JAMA Oncology Paper on Patient Preferences
00:44 Key Findings on Quality of Life vs Survival in Older Cancer Patients
01:17 Clinical Experience Discussing Quality of Life with Patients
02:17 Quality of Life as a Shifting and Individual Parameter
03:22 Respecting Patient Decisions on Treatment Intensity
04:13 Limitations of Quality of Life Metrics in Surveys and Papers
05:32 Emphasis on Respect, Listening, and Addressing Patient Fears
06:48 Concerns About AI Reducing Human Compassion in Medicine
07:33 Challenges in Delivering Bad News and Maintaining Dignity
08:50 Call for Physicians to Be More Human and Sensitive to Preferences


Don't know your stage? Take the quiz: visit prostatecancerstaging.org

To learn more about prostate cancer, visit pcri.org

Sign up for our newsletter here to receive the latest updates on prostate cancer and the PCRI: pcri.org/join

Who we are:

The Prostate Cancer Research Institute (PCRI) is a 501(c)(3) not-for-profit organization that is dedicated to helping you research your treatment options. We understand that you have many questions, and we can help you find the answers that are specific to your case. All of our resources are designed by a multidisciplinary team of advocates and expert physicians for patients. We believe that by educating yourself about the disease, you will have more productive interactions with your medical professionals and receive better-individualized care. Feel free to explore our website at pcri.org or contact our free helpline with any questions that you have at pcri.org/helpline. Our Federal Tax ID # is 95-4617875 and qualifies for maximum charitable gift deductions by individual donors.
Quality of Life Study | 2026 Mid-Year Update | Eugene Kwon, MD + Mark Moyad, MD Q&A #PCRILearn more about Cribriform #Gleason7 #pcriLympho-Vascular Invasion (LVI) #ProstateCancer Pathology | Jonathan Epstein, MD & Mark Moyad, MDProstate MRIs in 2025 | #MarkScholzMD #AlexScholz #PCRI #ProstateCancer2025 #PCRI Mens Health Conference #MarkScholzMD #MarkMoyadMD2024 Update | Lu-177 (Pluvicto), Actinium & New #ProstateCancer AntiBody | Dr. Nat Lenzo #AlexScholz2026 #PCRI Mens Health Conference #MarkScholzMD #MarkMoyadMDAll-Star PCRI Conference Moments With Mark Moyad, MD, MPH | #PCRIIvermectin, Mebendazole, & Prostate Cancer? |#MarkScholzMD #MarkMoyadMD #PCRISexual Recovery After ADT For #ProstateCancer | #MarkScholzMD #AlexScholz #PCRINew #ProstateCancer Abstracts ASCO 2025 | #MarkScholzMD #AlexScholz #PCRITargeted Biopsies For #ProstateCancer | #MarkScholzMD #AlexScholz #PCRI
Prostate Cancer Research Institute |

Quality of Life Study | 2026 Mid-Year Update | Eugene Kwon, MD + Mark Moyad, MD Q&A #PCRI

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER